Certis (Drug Discovery) is Drug Discovery in United States that focus on mouse models business. Founded in 2017. They cover business area such as developer, oncology intelligence, every patient, Orthotopic Patient-derive Xenograft, (o-PDX) mouse model, colon, brain, pancreas, liver, lung, specialized immunodeficient mouse, a live model, that unique cancer, oncologist, therapy, aggressive cancer.
2017
( 7 years old in 2024 )
Mouse Models
-
4940 Carroll Canyon Road
Suite 120
San Diego, CA 92121
United States
Private
developeroncology intelligenceevery patientOrthotopic Patient-derive Xenograft(o-PDX) mouse modelcolonbrainpancreasliverlungspecialized immunodeficient mousea live modelthat unique canceroncologisttherapyaggressive cancer
* We use standard office opening hours in near Certis (Drug Discovery)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Certis (Drug Discovery) is Drug Discovery business from United States that founded in 2017 (7 years old in 2024), Certis (Drug Discovery) business is focusing on Mouse Models.
Certis (Drug Discovery) headquarter office and corporate office address is located in 4940 Carroll Canyon Road Suite 120 San Diego, CA 92121 United States.
Certis (Drug Discovery) was founded in United States.
In 2024, Certis (Drug Discovery) is currently focus on mouse models sector.
Above is snippet of Google Trends for "mouse models" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Certis (Drug Discovery), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
